Drug Store News4d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Sanofi in talks to sell consumer healthcare business that makes Dulcolax
Analysts at Alphavalue said the reported deal price would value Opella at less than other consumer ... Sanofi in last year’s ...
赛诺菲出售Opella消费者健康业务50%股权，交易额达150亿欧元
赛诺菲公司宣布将其消费者医疗保健业务Opella 50%的控股权出售给私募股权公司CD&R，交易预计将于2025年第二季度完成。这项交易的价值约为150亿欧元（约合164亿美元），交易条款与先前披露的内容保持一致。
赛诺菲与CD&R达成协议，出售50%消费者健康部门股份
赛诺菲近日宣布，将其消费者医疗保健业务Opella的50%控股权出售给私募股权公司CD&R，交易价值约为150亿欧元（约合164亿美元）。这项交易的条款与之前披露的内容一致，预计最早将在2025年第二季度完成。
Nasdaq4d
Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R
In October last year, the company had announced that it has entered into exclusive negotiations to sell the stake in Opella to CD&R. The valuation of Opella was then based on an enterprise value ...
赛诺菲将向CD&R出售50%消费者健康部门股份
赛诺菲 (SNY.US)已达成一项股权购买协议，将其消费者医疗保健业务Opella 50%的控股权出售给私募股权公司CD&R。交易条款与之前披露的条款保持不变，预计最早将于2025年第二季度完成。 Opella总部位于法国，销售非处方药和维生素、矿物质和补品，旗下有100个品牌，包括Allegra、Doliprane、Novanight、Icy ...